| Literature DB >> 28910948 |
Abstract
This paper introduces the revised cochrane risk of bias tool for individually randomized, parallel group trials (RoB2.0), compates RoB2.0 and the previous version (RoB1.0). And illustrates the application of RoB2.0 for a published clinical trial. As a comprehensive tool, RoB2.0 provides more information on the risk of bias for evidence synthesis. RoB2.0 is still under development and it is suggested that the users should follow the updates of the developers in the future.Keywords: Parallel design; Randomized controlled trial; Risk of bias; Systematic review; Tool for assessment
Mesh:
Year: 2017 PMID: 28910948 DOI: 10.3760/cma.j.issn.0254-6450.2017.09.028
Source DB: PubMed Journal: Zhonghua Liu Xing Bing Xue Za Zhi ISSN: 0254-6450